If this was so good, then why isn't it getting sold down so hard and fast.I am concerned over the maiden resource.Still cheap though, but the signals are so mixed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025